Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer

[1]  F. Graur,et al.  Inflammatory Ratios as Predictors for Tumor Invasiveness, Metastasis, Resectability and Early Postoperative Evolution in Gastric Cancer , 2022, Current oncology.

[2]  F. Lordick,et al.  Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  T. Tomás,et al.  Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer , 2022, World journal of gastrointestinal oncology.

[4]  W. Polkowski,et al.  Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population , 2022, Cancers.

[5]  Zhigang Wang,et al.  Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer , 2021, Frontiers in Oncology.

[6]  Fenghua Wang,et al.  The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021 , 2021, Cancer communications.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  Chang-ming Huang,et al.  Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer , 2020, British Journal of Cancer.

[9]  M. Kanda,et al.  Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer , 2019, World journal of gastrointestinal oncology.

[10]  Zhen-ning Wang,et al.  Assessment of the 8th edition of TNM staging system for gastric cancer: the results from the SEER and a single-institution database. , 2018, Future oncology.

[11]  M. Kanda,et al.  Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer , 2018, The British journal of surgery.

[12]  Chang-ming Huang,et al.  Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging? , 2018, Annals of Surgical Oncology.

[13]  Masayoshi Yamamoto,et al.  The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  Qingsi He,et al.  Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer , 2017, Medicine.

[15]  M. Kanda,et al.  Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy , 2017, Digestive Surgery.

[16]  Yingchun Li,et al.  Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer , 2017, Journal of Cancer Research and Clinical Oncology.

[17]  Wei Wang,et al.  Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma , 2016, Oncotarget.

[18]  Jiewei Chen,et al.  Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients , 2016, Annals of Surgical Oncology.

[19]  C. Röcken,et al.  Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - a critical appraisal. , 2015, European journal of cancer.

[20]  J. Cheong,et al.  Prognostic Value of Early Postoperative Tumor Marker Response in Gastric Cancer , 2013, Annals of Surgical Oncology.

[21]  Kun-He Zhang,et al.  Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer , 2013, BMC Gastroenterology.

[22]  Takashi Kumada,et al.  Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy. , 2012, Journal of Hepatology.

[23]  M. Duffy,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. , 2010, Clinical chemistry.

[24]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[25]  H. Shimada,et al.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association , 2013, Gastric Cancer.

[26]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .